Sen. Orrin Hatch (Photo: Chip Somodevilla/Getty Images)

The Trump administration's new trade deal with Canada and Mexico includes a big win for pharmaceutical companies and Republicans — a provision to protect biologic drugs from competition for 10 years.

Why it matters: Republicans say this will spread the cost of developing new drugs beyond the U.S. market, lowering American drug prices. By shielding the drugs from generic competition in Canada and Mexico, the measure will also help pharmaceutical companies reap more profits abroad.

The big picture: Biologics are a class of highly complex, generally very expensive drugs.

  • New biologics get 12 years of market exclusivity in the U.S. market, but 10 years is longer than they currently receive in Canada or Mexico. It's also much longer than the Obama administration had negotiated in its trade deals.
  • In the Obama era, “both countries said unequivocally that they weren’t going to move beyond five years … so to get this result is almost miraculous," said a former senior GOP official intimately involved in Obama and Trump-era trade negotiations.
  • "It will add cost to their national health care systems ... especially in Canada," the official added, but will lead to the creation of new cures “without the United States being the piggy bank for all those research and development dollars."

What we're watching: This was a key issue in the fight over the Trans-Pacific Partnership. Senate Finance Committee Chairman Orrin Hatch argued that the exclusivity period for biologics was not long enough in that deal.

  • “Chairman Hatch continues to believe that the standard of protection for biologics should be consistent with U.S. law, but he is encouraged that the administration was able to secure 10 years of data protection with Canada and Mexico, the highest standard in any trade agreement," a spokesman said in a statement yesterday.

What they're saying: “We feel this is bad news for patients who are seeking more affordable biologics. It would delay biosimilar competition," Jeff Francer, general counsel for the Association for Accessible Medicines, told Axios when the administration's trade deal with Mexico — also featuring a 10-year protection period — was announced in August.

Go deeper

Updated 2 mins ago - Politics & Policy

Coronavirus dashboard

Illustration: Sarah Grillo/Axios

  1. Global: Total confirmed cases as of 2 p.m. ET: 18,147,574 — Total deaths: 690,573 — Total recoveries — 10,753,815Map.
  2. U.S.: Total confirmed cases as of 2 p.m. ET: 4,687,828 — Total deaths: 155,062 — Total recoveries: 1,468,689 — Total tests: 56,812,162Map.
  3. Politics: White House will require staff to undergo randomized coronavirus testing — Pelosi says Birx "enabled" Trump on misinformation.
  4. Business: Virtual school is another setback for retail — The pandemic hasn't hampered health care.
  5. Public health: Former FDA chief says MLB outbreaks should be warning sign for schools.

Filing suggests Manhattan DA is investigating Trump for possible fraud

Photo: Brendan Smialowski/AFP

The Manhattan District Attorney's office suggested for the first time Monday that it's investigating President Trump and his company for "alleged bank and insurance fraud," the New York Times first reported.

The state of play: The disclosure was made in a filing in federal court that seeks to force accounting firm Mazars USA to comply with a subpoena for eight years of Trump's personal and corporate tax returns.

House Democrats subpoena top Pompeo aides in probe of IG firing

Mike Pompeo. Photo: Jim Lo Scalzo-Pool/Getty Images

The Democratic chairs of the House Oversight and House Foreign Affairs committees announced subpoenas Monday for four State Department officials as part of their investigation into the firing of former Inspector General Steve Linick.

Why it matters: The two committees, in addition to Democrats on the Senate Foreign Relations Committee, are investigating whether Linick was fired because he was probing Secretary of State Mike Pompeo and the State Department's attempts to bypass Congress to sell weapons to Saudi Arabia and the United Arab Emirates.